Please login to the form below

Not currently logged in
Email:
Password:

Allergan appoints Douglas Ingram as first president

Promotion for company veteran

Allergan-Douglas-IngramAllergan has appointed company veteran Douglas Ingram as the company's first president.

Ingram, who has spent 17 years at Allegan, will lead the company's global commercial operations, holding responsibility for a product portfolio that includes Botox as well as several ophthalmology treatments.

He most recently spent three years as executive VP and president, Europe, Africa and Middle East (EAME).

Other roles during his extensive period at Allergan include chief administrative officer and chief ethics officer.

He rose to these roles having joined the company as senior attorney and chief litigation officer in 1996.

Before joining Allergan, Ingram was an attorney with Gibson, Dunn & Crutcher from 1988, practicing in the area of complex commercial litigation.

"Doug has built an impressive record of accomplishment and is widely regarded throughout our organisation as a leader who is committed to the highest standards of excellence in all areas,” said David Pyott, chairman of the board and CEO, Allergan.

27th June 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics